Site Search
Search Results
Gov. Moore Approves Legislation to Expand Access to Biomarker Testing
... HB 1217 / SB 805—among many other bills—into law. This legislation will increase insurance coverage for biomarker testing, making this form of precision medicine available to more Marylanders. The signing ceremony will take place today at 12:00pm in the State House. “Today is a win ... and patients across Maryland,” said Lance Kilpatrick, Government Relations Director for the American Cancer Society Cancer Action Network (ACS CAN) in Maryland. “This legislation will help expand access and bring the promise of precision medicine to patients dealing with cancer and other diseases, including arthritis, other autoimmune conditions and rare diseases, no ...
Maryland Lawmakers Overwhelmingly Support Increasing Access to Biomarker Testing
... 17, 2023 – Last week, HB 1217 / SB 805 landed on Governor Wes Moore’s desk following its near-unanimous passage in the Senate and House of Delegates and representing a victory for cancer patients across Maryland. The legislation aims to ensure biomarker testing is covered by all ... We are thrilled at the prospect of securing such progress for Marylanders.” Sen. Ellis continued, “This legislation will help dismantle cost barriers and bring the promise of precision medicine to cancer patients and survivors across Maryland, no matter their income, race or where they live.” “Hearing the three simple words ‘you have cancer’ can turn anyone’s world upside down. Progress in improving cancer outcomes increasingly involves the use of precision medicine which allows more ...
Maryland State Budget Produces Mixed Results in Fight against Cancer
Maryland state lawmakers have released details on the agreed upon 2025-26 budget—the contents of which are a mixed bag in the fight against cancer. While the state made sound investments in cancer research and protected Medicaid recipients’ ability to access biomarker testing, it missed an opportunity to save the lives and lungs of Maryland’s youth by cutting funding for the state’s tobacco prevention and cessation programs. To mark both the victories and missed opportunities, Lance Kilpatrick, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Maryland, responded with the following statement: “With looming threats to cancer research funding in D.C. and so many lives hanging in ...